Companies: 10,795·Total market cap: $144.5T
Merus N.V.

Merus N.V.

MRUSNASDAQHealthcare
$90.00
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio—
52W High$97.14
52W Low$33.19
Cash on HandFinancialsRevenue

Merus N.V. (MRUS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MRUS · cash on hand · updated Dec 31, 2024

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$537.0M▲ +51.2% vs prior year
FY · as of Dec 31, 2024 · Reported in USD
Cash & Cash Equiv. (CCE)
$293.3M
cashAndCashEquivalents
Short-Term Investments
$243.7M
shortTermInvestments
YoY Change vs Prior Year
+51.2%
vs prior fiscal year
Latest Quarter
$543.0M
Q3 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash & ST Investments$537.0MCash on Hand
Total Debt$9.9MTotal Debt
Net Cash / Net Debt+$527.1MNet Cash Position
Cash vs Debt Ratio
Cash 98%Debt 2%

Merus N.V. has a net cash position of $527.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$537.0M − $9.9M = +$527.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MRUS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2024Latest$537.0M+51.2%
Dec 31, 2023$355.2M+22.4%
Dec 31, 2022$290.2M-29.3%
Dec 31, 2021$410.4M+97.6%
Dec 31, 2020$207.8M-1.6%
MRUS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Merus N.V.
Merus N.V.YOU
MRUS
$537.0M7.9%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Merus N.V. (MRUS) cash on hand as of December 31, 2024 is $537.0M, comprising $293.3M in cash and cash equivalents (CCE) plus $243.7M in short-term investments — reported as Merus N.V. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Merus N.V. cash reserves or cash position.

Merus N.V. annual cash on hand history shows increased +51.2% in 2024: increased +51.2% in 2024. Merus N.V. cash reserves in 2024 reflect the company's capital allocation strategy.

Merus N.V. carries total debt of $9.9M against cash of $537.0M, resulting in a net cash position of +$527.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MRUS cash on hand · 5 questions

As of December 31, 2024, Merus N.V. (MRUS) has $537,027,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $293,294,000 in cash and cash equivalents (CCE) plus $243,733,000 in short-term investments. Latest quarter (September 30, 2025): $542,952,382. Data sourced from the annual 10-K filing via FMP.

MRUS cash on handMRUS cash reservesMRUS cash 2024how much cash does MRUS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Merus N.V. · Merus N.V. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024